Atossa Genetics, Inc. to Present at Upcoming Investor Conferences in September 2016
12. September 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 12, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced it will be a featured presenter at the Rodman & Renshaw 18th Annual Global Investment...
Atossa Genetics, Inc. Prices Underwritten Public Offering of 1,150,000 Common Shares
31. August 2016 06:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 31, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS), today announced the pricing of an underwritten public offering of 1,150,000 shares of its common stock at a price...
Atossa Genetics Inc. Announces Proposed Public Offering of Common Stock
30. August 2016 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 30, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it intends to offer for sale shares of its common stock in an underwritten public offering. The...
Atossa Genetics Announces Reverse Stock Split
25. August 2016 12:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 25, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced a reverse split of its common stock at a ratio of 1-for-15, effective August 26, 2016, and that the...
Atossa Genetics Announces Second Quarter 2016 Financial Results and Provides Company Update
12. August 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 12, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced Second Quarter ended June 30, 2016 financial results and provided an update on recent company...
Atossa Genetics to Provide Company Update and Discuss Second Quarter Financial Results on Conference Call on Monday, August 15, 2016
10. August 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 10, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will provide a Company update and discuss second quarter 2016 financial results on Monday,...
Atossa Genetics Settles Litigation With Besins Healthcare
05. August 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 5, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) and Besins Healthcare Luxembourg SARL ("Besins") have agreed, pursuant to a Termination Agreement dated August 4,...
Atossa Genetics Initiates Additional Drug Development Program
07. Juni 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 7, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has initiated a new drug development program with oral endoxifen. Endoxifen is an active...
Atossa Genetics Announces $10 Million At-the-Market Common Stock Purchase Agreement With Aspire Capital Fund, LLC
27. Mai 2016 08:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 27, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that it has entered into a $10 million stock purchase agreement with Aspire Capital Fund, LLC. Under...
Atossa Genetics Announces First Quarter 2016 Financial Results and Provides Company Update
05. Mai 2016 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 5, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced First Quarter ended March 31, 2016 financial results and provided an update on recent company...